On January 11, 2021, Noctrix Health, Inc. closed the transaction. The transaction was co-led by new investors Treo Ventures and OrbiMed Advisors LLC. The transaction also included participation from LivaNova PLC (NasdaqGS:LIVN) and other insiders. As part of the transaction, Tracy Pappas from Treo Ventures and Chau Khuong from OrbiMed Advisors LLC will join the board of directors of the company. The company received $16,882,432 from 11 investors pursuant to exemption provided under Regulation D.